ES2008204A6 - Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos. - Google Patents

Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos.

Info

Publication number
ES2008204A6
ES2008204A6 ES878702586A ES8702586A ES2008204A6 ES 2008204 A6 ES2008204 A6 ES 2008204A6 ES 878702586 A ES878702586 A ES 878702586A ES 8702586 A ES8702586 A ES 8702586A ES 2008204 A6 ES2008204 A6 ES 2008204A6
Authority
ES
Spain
Prior art keywords
pib
baculoviruses
heterologous protein
producing
mixed composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES878702586A
Other languages
English (en)
Inventor
David W Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of ES2008204A6 publication Critical patent/ES2008204A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

METODO PARA PRODUCIR CUERPOS DE INCLUSION POLIHEDRICA DE COMPOSICION MEZCLADA (PIB), PARA COINFECTAR INSECTOS HUESPEDES Y PARA PRODUCIR HETEROLOGAS EN INSECTOS. LOS PIB, CONTENIENDO UNA MEZCLA DE NUCLEOCAPSIDOS DE POR LO MENOS DOS BACULOVIRUS GENETICAMENTE DISTINTOS, SE OBTIENEN INFECTANDO UN CULTIVO CELULAR DE CELULAS QUE TOLERAN EL BACULOVIRUS CON LA FORMA NO OCLUIDA DE LOS BACULOVIRUS GENETICAMENTE DISTINTOS Y CULTIVANDO LAS CELULAS INFECTADAS, O BIEN INFECTANDO UN INSECTO CON LOS BACULOVIRUS GENETICAMENTE DISTINTOS. LA COINFECCION DEL INSECTO HUESPED SE EFECTUA PERMITIENDO QUE EL INSECTO INGIERA UNA CANTIDAD EFICAZ DEL PIB LO QUE ORIGINA UNA INFECCION VIRICA MIXTA EN EL MISMO. DESARROLLANDO EL INSECTO O CELULAS EN CONDICIONES ADECUADAS QUE PERMITAN LA REPLICACION VIRICA, SE CONSIGUE LA PRODUCCION DE PROTEINAS HETEROLOGAS CODIFICADAS POR EL GEN HETEROLOGO PRESENTE EN UNO DE LOS BACULOVIRUS. APLICACION EN INGENIERIA GENETICA PARA LA SINTESIS DE PROTEINAS HETEROLOGAS EN CELULAS DE INSECTOS.
ES878702586A 1986-09-09 1987-09-08 Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos. Expired ES2008204A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90572986A 1986-09-09 1986-09-09

Publications (1)

Publication Number Publication Date
ES2008204A6 true ES2008204A6 (es) 1989-07-16

Family

ID=25421367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES878702586A Expired ES2008204A6 (es) 1986-09-09 1987-09-08 Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos.

Country Status (8)

Country Link
EP (1) EP0323974B1 (es)
JP (1) JPH02500402A (es)
AU (1) AU601232B2 (es)
CA (1) CA1330426C (es)
DE (1) DE3788352T2 (es)
ES (1) ES2008204A6 (es)
WO (1) WO1988002030A1 (es)
ZA (1) ZA876696B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810808D0 (en) * 1988-05-06 1988-06-08 Wellcome Found Vectors
JP2511494B2 (ja) * 1988-05-12 1996-06-26 善治 松浦 日本脳炎ウイルス表面抗原蛋白質の製造法
WO1990001556A1 (en) * 1988-08-05 1990-02-22 Mount Sinai School Of Medicine Of The City University Of New York In vivo infection of live insects with a recombinant baculovirus
AU4647889A (en) * 1988-11-18 1990-06-12 Cetus Corporation Insect signal peptide mediated secretion of recombinant proteins
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
US5145775A (en) * 1989-02-28 1992-09-08 Research Association For Biotechnology Of Agricultural Chemicals Polyhedrin gene and genetic engineering thereof
GB9219562D0 (en) 1992-03-11 1992-10-28 Prendergast Kennet F Anti-viral peptides
US6130074A (en) * 1992-06-01 2000-10-10 American Cyanamid Company Five Giralda Farms Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
HU218849B (hu) * 1992-06-01 2000-12-28 American Cyanamid Co. Gazdaszervezetről gazdaszervezetre a környezetben csökkent terjedési képességgel rendelkező rekombináns bakulovirus és eljárás előállítására
DE69632658T2 (de) * 1995-03-14 2005-06-09 Akzo Nobel N.V. Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
EP3049516B1 (en) 2013-09-23 2018-07-25 Universidad Pública De Navarra Production of virus occlusion bodies that occlude virions comprising genomes of different species of baculoviruses that can be used to combat insect pests

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK518384A (da) * 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
EP0222412B1 (en) * 1985-11-14 1992-11-19 Daiichi Pharmaceutical Co., Ltd. Method of producing peptides
NZ221702A (en) * 1986-09-08 1989-02-24 Bishop David H L Expression of human hepatitis b antigens in insects and cultured insect cells using recombinant baculoviruses

Also Published As

Publication number Publication date
ZA876696B (en) 1988-05-25
AU601232B2 (en) 1990-09-06
EP0323974B1 (en) 1993-12-01
EP0323974A4 (en) 1990-02-21
JPH02500402A (ja) 1990-02-15
DE3788352D1 (de) 1994-01-13
EP0323974A1 (en) 1989-07-19
DE3788352T2 (de) 1994-03-17
CA1330426C (en) 1994-06-28
AU8032387A (en) 1988-04-07
WO1988002030A1 (en) 1988-03-24

Similar Documents

Publication Publication Date Title
AU586319B2 (en) Method for priming hard tissue
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
AU5443890A (en) Improvements in or relating to enhancers
LU91006I2 (en) Neupopeg-pegfilgrastim et ses dérivés pharmaceutiquement acceptables
EP0175261A3 (en) Hybrid particle immunogens hybrid particle immunogens
NZ224581A (en) Hiv-2 peptide, aids vaccine
DE3586801D1 (de) Synthetische hepatitis-b-virus-vakzine die t-zellen- und b-zellenbestimmer enthalten.
HK5692A (en) Oral vaccines
EP0111389A3 (en) Substantially pure porcine growth hormone, dna sequences therefor, and expression vehicles and transfected microorganisms for the production of porcine growth hormone
EP0272858A3 (en) Recombinant hiv envelope proteins produced in insect cells
CA2019803A1 (en) Feline interferon and process for production thereof
GR3000708T3 (en) Lyophilized composition containing ifosfamide, and process for its preparation
DK0396436T3 (da) Gærstammer til fremstilling af modne heterologe proteiner, især hirudin
EP0400569A3 (en) Method for preparing a vaccine from Streptococcus mutans for dental caries and vaccinal compositions for dental caries used as nasal drops
EP0255242A3 (en) Oncornavirus vaccines
AU1090688A (en) Synthetic porcine growth hormone
NZ220645A (en) Modified varicella-zoster virus and its cultivation
WO1990015810A3 (en) Improved process for preparing isepamicin
WO1988000836A3 (fr) Immunosuppresseur et son procede de fabrication
AU3964085A (en) Novel expression plasmids containing the full cDNA sequence of calf prochymosin
FI860599A0 (fi) Foerfarande foer framstaellning av 4-(2-metoxietyl)-fenylglycidyleter och/eller metoprolol.
Lasky et al. Production of an HSV subunit vaccine by genetically engineered mammalian cell lines.
EP0239075A3 (en) Process for producing fish growth hormone polypeptide
JPS57109705A (en) Dental inorganic adhesive
EP0205625A4 (en) VACCINE AGAINST HEPATITIS B VIRUS AND PREPARATION METHOD.